Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard ®) - are equally effective for ...

Add the following CSS to the header block of your HTML document. Then add the mark-up below to the body block of the same document. .videoWrapper { position: relative; padding-bottom: 56.25%; ...

Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study. Unlike ...

About The Study: This study found that comparable levels of sensitivity and specificity as reported for the multitarget stool RNA (mt-sRNA) test in the colorectal cancer (CRC)-PREVENT study could be ...

Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionately impacts people who receive care in under-resourced settings. Fortunately, several ...

Please provide your email address to receive an email when new articles are posted on . Annual fecal immunochemical testing was the most effective and cheapest CRC screening method for underserved ...

Known differences in colorectal cancer characteristics between men and women are also observed in fecal immunochemical tests.

Q: My doctor always encourages me to do a colonoscopy for colorectal cancer screening. But I have friends who just do a stool test at home, which seems easier. Why should I go through the hassle of a ...

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the ...

Study finds FIT misses more cancers and precancerous lesions in women at standard threshol ...

A large screening study across 13 regions of Shandong Province, China, finds that a fecal immunochemical test threshold of 25 µg/g detects 96.4% of colorectal cancers while cutting the colonoscopy ...